Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Muna Bhanji Insider Profile
4 Followers
Muna Bhanji, Director at Cytokinetics, holds 19.73K shares in Intellia Therapeutics (Ticker: NTLA), holds 23.11K shares in Veracyte (Ticker: VCYT), holds 17.63K shares in Cytokinetics (Ticker: CYTK).
Muna Bhanji has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Muna Bhanji holds in companies
Most Profitable Insider Trade
The most profitable trade made by Muna Bhanji
Muna Bhanji's Trading History
Cytokinetics
Jun 10, 2024
Director
Informative Sell
104.14K
$929.33K
Ardelyx
Jun 17, 2022
Director
Uninformative Buy
―
$621.75K
Veracyte
Jun 11, 2024
Director
Uninformative Sell
78.60K
$503.46K
Intellia Therapeutics
Jun 14, 2024
Director
Uninformative Buy
―
$512.27K
List of latest transactions for each holding click on a transaction to see Muna Bhanji's performance on stock
You May Also Like
Muna Bhanji insider profile FAQ
What is the percentage of profitable transactions made by Muna Bhanji?
The percentage of profitable transactions made by Muna Bhanji is ―.
What is the average return per transaction made by Muna Bhanji?
The average return per transaction made by Muna Bhanji is ―.
What stocks does Muna Bhanji hold?
Muna Bhanji holds: CYTK, ARDX, VCYT, NTLA stocks.
What was Muna Bhanji’s latest transaction?
Muna Bhanji latest transaction was an Uninformative Buy of ―.
What was Muna Bhanji's most profitable transaction?
Muna Bhanji’s most profitable transaction was an Informative Sell of CYTK stock on July 7, 2023. The return on the trade was -39.70%.
What is Muna Bhanji's role in Cytokinetics?
Muna Bhanji's role in Cytokinetics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.